ADMA
ADMA Biologics·NASDAQ
--
--(--)
--
--(--)
ADMA Profile
Adma Biologics, Inc.
A company that develops specialty plasma-based biologics for the treatment and prevention of infectious diseases
465 State Route 17, Ramsey, New Jersey 07446
--
ADMA Biologics, Inc., was incorporated as a New Jersey corporation on June 24, 2004 and re-incorporated in Delaware on July 16, 2007. The Company is an end-to-end commercial biopharmaceutical company headquartered in the United States that manufactures, markets and develops specialty biological products for immunodeficient patients and populations at risk for specific infectious diseases. It sells three FDA-approved products — ASCENIV, BIVIGAM and Nabi-HB — which are manufactured at its Florida facility and operate an FDA-licensed plasma collection center.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
